Real-life study in non-atopic severe asthma patients achieving disease control by omalizumab treatment

Affiliations

• ¹ Allergy Unit, IBIMA-Regional University Hospital of Málaga, ARADyAL, Málaga, Spain.
• ² Pneumology and Allergy Unit, University Hospital of Jerez, Cádiz, Spain.
• ³ Novartis Farmacéutica, Barcelona, Spain.
• ⁴ Department of Allergy, La Paz Hospital Institute for Health Research (IdiPAZ), Centro de investigación en red de enfermedades respiratorias (CIBERES), Madrid, Spain.
• ⁵ Pneumology Unit, Costa del Sol Hospital, Marbella, Málaga, Spain.
• ⁶ Pneumology Service, University Hospital Doctor Peset, Valencia, Spain.
• ⁷ Pneumology Service, University Hospital Basurto, Bilbao, Spain.
• ⁸ Allergy Service, University Hospital of Salamanca and Institute for Biomedical Research of Salamanca (IBSAL), Biomedical and Diagnosis Science Department, Salamanca University School of Medicine, Salamanca, Spain.